On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Lack of Timely Follow-up Care After Heart Failure Common in Type 2 DiabetesJune 7th 2023
An analysis of Medicaid data from adults in Alabama suggests just more than 50% of patients fail to get ambulatory follow-up care within the recommended 14-day window following a first-time heart failure hospitalization.
Investigators Find 3 Novel Loci to Better Understand Genetic Factors of Sleep ApneaJune 7th 2023
CCDC3 has shown to repress inflammatory activity of TNF-alpha, a cytokine postulated involved in sleep regulation and MARCHF1 has shown to inhibit cellular insulin sensitivity and promotes NF-KB, with degree of activation positively correlating with OSA severity.
Newly-Developed Sulfa Antibiotic Allergy Clinical Decision Rule Shows Strong ResultsJune 7th 2023
Adaptation of penicillin allergy clinical decision tool PEN-FAST showed strong performance, indicating the potential utility of the tool for identifying patients with low-risk allergy phenotypes who may safely undergo direct oral challenges.
Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers RemainJune 7th 2023
More than 90% of respondents reported being “somewhat likely” or “very likely” to speak with an online coach ≥2 per week or spend 1 – 2 hours per week learning about lifestyle behaviors if given the opportunity.
Strong Long-Term Trial Data for Adalimumab Observed for HS Patients in Real World SettingsJune 7th 2023
In the results of this final analysis, the hidradenitis suppurativa drug was found to be well tolerated in patients regardless of either differing demographics or clinical characteristics.
4 Psoriasis Biosimilars Showing No Major Differences with Originators in Efficacy, SafetyJune 6th 2023
These 4 treatments and their biosimilars show no significant differences, though future studies may be necessary to assess long-term efficacy and safety of biosimilars in treating psoriasis.
Study Captures Patient Perspective When Considering Discontinuation of Gout TherapyJune 6th 2023
Data presented at EULAR 2023 details the factors that matter most to patients with gout when considering the continuation or discontinuation of urate-lowering therapy after achieving clinical remission.
Advanced Brain Aging Observed in Older Type 1 Diabetes Patients Compared to Those WithoutJune 6th 2023
This research supports the notion that brain morphology may be related to acceleration in the aging process for middle-aged and older-aged adults who have a long history of type 1 diabetes.
Disease Activity-Guided Dosing Safe, Effective for up to 10 Years in Rheumatoid ArthritisJune 6th 2023
Noortje van Herwaarden, MD, PhD, discusses the results of a 10-year follow-up from the DRESS study and how it informs use of disease activity-guided dose optimization in treatment of rheumatoid arthritis.